Add Yahoo as a preferred source to see more of our stories on Google. As women enter perimenopause and begin to transition into menopause, questions inevitably arise. How long can I expect these ...

A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though ...

"The magnitude of this difference warrants future studies." HealthDay News — Postmenopausal women who used hormone therapy lost significantly more weight while taking tirzepatide than women only ...

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women on hormone therapy had higher total body weight loss with semaglutide for up to 12 months ...

The timing matters, as one expert says it's all part of health discussions "to prevent chronic conditions in the future." ...

Estradiol hormone therapy was associated with higher memory scores in postmenopausal women. Transdermal estradiol was linked with better episodic memory, while oral estradiol was tied to prospective ...

Menopause can have profound effects on heart health, yet many people are unaware of this important connection. The hormonal shifts occurring during menopause mark the end of a woman’s reproductive ...

Postmenopausal hormone therapy is not associated with increased risk of stroke, provided that it is started early, according to a report from Karolinska Institutet in Sweden published in the journal ...

Menopause has long been a hush-hush topic, something on the periphery of our minds that no one really wants to talk about. (Except maybe in hushed whispers with your best friend while fanning yourself ...

Menopause involves the permanent stopping of menstruation. There is a distinct drop in estrogen that occurs in menopause. Hormone therapy can help minimize certain menopause symptoms like hot flashes ...

Those who used menopausal hormone therapy had a 27 to 34% lower mortality hazard than those who did not. HealthDay News — Menopausal hormone therapy is not associated with an increased risk for ...

ORLANDO -- Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, ...